Summary
During a time period of 8 years 55 female patients between age 15 and 40 with cerebrovascular accidents (CVA) were seen by us. 19 were pregnant, 9 had migraine accompagnéc, 2 showed embolisms, 3 had a hematologic disorder, in 2 cases there was juvenile subcortical bleeding, 2 had a thrombosis of the internal carotid artery, and in 5 cases no specific etiological factor was found. The remaining 11 cases were young women taking the “pill” at the time of the CVA. Two other patients age 42 and 45 years, respectively, with a CVA were on the same medication, and in still 2 more females the medication had precipitated migraine accompagnée followed by cerebrovascular accident. One patient with a CVA during the first month of her pregnancy had taken an oral contraceptive for the 2 preceding years. Adding 4 more females seen after the manuscript of this paper was submitted we have by now observed a total of 20 patients in whom the pill may be implicated in the development of a CVA. The average age of the patients was 29 years. The drug regimens comprised 7 different brands which had bee taken for periods from 14 days to 36 months. In 17 cases hemiplegia was present, and in 2 others there was a global amnestic episode. On the basis of our observations and of 80 cases reported in the medical literature pathogenetic mechanisms of the “pill” are discussed. Statistic evidence supports the assumption that it may play a pathogenetic role, as does experimental work on the influence of contraceptives on blood clotting mechanisms and on histologic alterations of the vascular walls. Common features of the state of pregnancy and the administration of the “pill” are stressed.
Zusammenfassung
Aus dem Krankengut von 8 Jahren werden 55 Frauen im Alter zwischen 15 und 40 Jahren analysiert, die einen vasculären cerebralen Insult durchmachten. Bei 19 derselben trat der Insult im Rahmen einer Gravidität auf, bei 9 in Zusammenhang mit einer Migraine accompagnée, bei 2 durch eine Embolie, bei 3 im Rahmen einer Blutkrankheit, bei 2 lag eine juvenile subcorticale Blutung, bei 2 weiteren eine Carotisthrombose vor, und bei 5 war kein sicherer ätiologischer Faktor eruierbar. Demgegenüber standen 11 Fälle, die zur Zeit des Insultes Ovulationshemmer einnahmen. Hinzu kommen 2 weitere Frauen im Alter von 42 und 45 Jahren, die Ovulationshemmer nahmen, 2 bei denen durch die Einnahme von Ovulationshemmern eine Migraine accompagnée ausgelöst wurde, und eine weitere, die bis unmittelbar vor einer zweiten Schwangerschaft, in welcher ein Insult auftrat, 2 Jahre lang Ovulationshemmer eingenommen hatte. Fügt man 4 Fälle hinzu, bei welchen nach Abschluß dieser Arbeit unter Ovulationshemmern ein Insult sich ereignete, so verfügen wir insgesamt über 20 Beobachtungen, bei welchen die Einnahme von Ovulationshemmern pathogenetisch eine Rolle beim Zustandekommen eines vasculären cerebralen Insultes spielen könnte. Das Durchschnittsalter der Patientinnen beträgt 29 Jahre, die Dauer der Einnahme der Ovulationshemmer variiert zwischen 36 Monaten und 14 Tagen. Die Marke spielt keine Rolle. Zusätzliche pathogene Faktoren sind nur in vereinzelten Fällen vorhanden. Die Symptomatologie besteht außer in 2 Fällen mit einer amnestischen Episode in einer Hemiparese. An Hand der eigenen Beobachtungen sowie von 80 Fällen aus der Literatur wird der mögliche pathogenetische Mechanismus diskutiert. Es werden die Argumente, die für eine echte kausale Beziehung sprechen, im einzelnen angeführt.
Similar content being viewed by others
Literatur
Altshuler, J. H., Laughlin, R. A., Neubuerger, K. T.: Neurological catastrophe related to oral contraceptives. Arch. Neurol. (Chic.) 19, 264–273 (1968).
Arbenz, J. P., Wormser, P.: Pseudotumor cerebri durch Sexualhormone. Schweiz. med. Wschr. 95, 1654–1656 (1965).
Baines, G. F.: Cerebrovascular accidents and oral contraception. Brit. med. J. 1965 I, 189.
Behrmann, S.: Homonymous hemiaopsia after oral contraceptives. Brit. med. J. 1967 II, 684.
Bergeron, R. Th., Wood, E. H.: Oral contraceptives and cerebrovascular complications. Radiology 92, 231–238 (1969).
Bickerstaff, E. R., Holmes, J. M.: Cerebral arterial insufficiency and oral contraceptives. Brit. med. J. 1967 I, 726–729.
Bole, G. G., Friedlaender, M. H., Smith, C. K.: Rheumatic symptoms and serological abnormalities induced by oral contraceptives. Lancet 1969 I, 323–326.
Boyce, J., Fawcett, J. W., Noall, E. W. P.: Coronary thrombosis and conovic. Lancet 1963 I, 111.
Bradford, D. E.: Cerebral thrombosis and oral contraception (letter of the editor). Lancet 1967 I, 679–680.
Brodsky, I., Lewis, G., jr., Ross, E.: Effect of pregnancy or a progestational drug on blood coagulation as measured by the thrombotest. Obstet. Gynec. 24, 213–217 (1964).
Caron, G. A.: Contact lenses and oral contraceptives. Brit. med. J. 1966 I, 980.
Cole, M.: Stroke in young women using oral contraceptives. Arch. intern. Med. 120, 551–555 (1967).
Crocker, D. W.: Fibromuscular dysplasias of renal artery. Arch. Path. 85, 602–613 (1968).
Cross, J. N., Castro, P. O., Jennett, W. B.: Cerebral strokes associated with pregnancy and the puerperium. Brit. Med. J. 1968 I, 214–218.
Cutts, J. H.: Vascular lesions resembling periarteritis nodosa in rats undergoing prolonged stimulation with oestrogen. Brit. J. exp. Path. 47, 401–404 (1966).
Daly, R. J., Kane, F. J., jr., Ewing, J. A.: Psychosis associated with the use of a sequential oral contraceptive. Lancet 1967 II, 444–445.
Danforth, D. N., Manolo-Estrella, P., Buchingham, J. C.: The effect of pregnancy and of Enovid on the rabbit vasculature. Amer. J. Obstet. Gynec. 88, 952–962 (1964).
Davies, D. M., Lund, J. F.: Myaltia and an oral contraceptive. Lancet 1965 II, 1187.
De Gennes, J. L., Maunand, B., Sacks, M., Truffert, J.: Thrombose de la carotie interne après un seul cycle de contraceptifs oraux. Bull. Soc. Méd. Paris 118, 899–917 (1967).
Ecker, J. A., McKitterick, J. E., Failing, R. M.: Thrombosis of the hepatic veins. The “Budd-Chiari-Syndrome”. A possible links between oral contraceptives and thrombosis formation. Amer. J. Gastroent. 45, 429–443 (1966).
Egeberg, O., Owren, P. A.: Oral contraception and coagulability. Brit. med. J. 1963 I, 220–221.
Ehtishammuddin, M.: Vertebral-artery thrombosis and oral contraceptives. Brit. med. J. 1965 I, 921–922.
Elliott, F. A.: Contraceptive rills. (Letter to the editor). J. Amer. med. Ass. 206, 2742 (1968).
Erickson, L. R., Peterka, E. S.: Sunlight sensitivity from oral contraceptives. J. Amer. med. Ass. 203, 980–981 (1968).
Fernando, S. J. M.: An attack of chorea complicating oral contraceptive therapy. Practitioner 197, 210–211 (1966).
Filippa, G., Regli, F., Noseda, G.: Kausalzusammenhänge zwischen Einnahme oraler Kontrazeptiva und neurologischen Komplikationen? Münch. med. Wschr. 13, 691–698 (1967).
Gardner, J. H., van den Noort, S., Horenstein, S.: Cerebrovascular disease in young women taking oral contraceptives. Neurology (Minneap.) 17, 297–298 (1967).
Goddard, J. L. (Commissioner of food and drugs), US Department of Health, Education and Welfare. GPO 0-311–464, 1968.
Grandjean, Ph.: Ovulationshemmer und Nervensystem. Ther. Umsch. 27, 369–373 (1970).
Grant, E. C. G., Mears, E.: Mental effects of oral contraceptives. Lancet 1967 II, 945–946.
Haller, J.: Ovulationshemmung durch Hormone. Stuttgart: Thieme 1965.
Harris, P. W. R.: Malignant hypertension associated with oral contraceptives. Lancet 1969 II, 466–467.
Hauser, G. A., Schubiger, V.: Nebenerscheinungen der ovulationshemmenden Präparate. Arch. Gynäk. 202, 175–182 (1965).
Hazzard, W. R., Spiger, M. J., Bagdada, J. D., Bierman, E. L.: Studies on the mechanism of increased plasma triglyceride levels induced by oral contraceptives. New Engl. J. Med. 280, 471–474 (1969).
Heinen, G.: Über Ovulationshemmer. Hippokrates (Stuttg.) 38, 53–60 (1967).
Heyman, A., Arons, M., Quinn, M. G., Camplong, L.: The role of oral contraceptive agents in cerebrovascular disease. Facts and fancy. Zit. b. Schoenberg. Trans. Amer. neurol. Ass. 93, 219 (1968).
—: The role of oral contraceptive agents in cerebral arterial occlusion. Neurology (Minneap.) 19, 519–524 (1969).
Hollwich, F., Verbeck, B.: Nebenwirkungen der Ovulationshemmer am Auge. Dtsch. med. Wschr. 94, 1761–1765 (1969).
Horne, C. H. W., Howie, P. W., Weir, R. J., Goudie, R. B.: Effect of combines oestrogen-progestogen oral contraceptives on serum-levels of alpha2 Macroglobulin, Transferrin, Albumin and IgG. Lancet 1970 I, 49–51.
Huber, P., Fuchs, W. A.: Gibt es eine fibromuskuläre Hyperplasie zerebraler Arterien? Fortschr. Röntgenstr. 107, 119–126 (1967).
Humphrey, J. G., Newton, T. H.: Internal carotid artery occlusion in young adults. Brain 83, 565–578 (1960).
Hutchinson, E. C., Yates, P. O.: Cerebral ischaemia and extra-cerebral vascular disease. Postgrad. med. J. 36, 14–22 (1960).
Illis, L., Kocen, R. S., McDonald, W. I., Mondkar, V. P.: Oral contraceptives and cerebral arterial occlusion. Brit. med. J. 1965 II, 1164–1166.
Inman, W. H. W., Vessey, M. P.: Investigation of deaths from pulmonary, coronary and cerebral thrombosis and embolism in women of child-bearing age. Brit. med. J. 1968 II, 193–199.
Irey, N. S., Manion, W. C., Taylor, H. B.: Vascular lesions in women taking oral contraceptives. Arch. Path. (Chic.) 89, 1–8 (1970).
Jennett, W. B., Cross, J. M.: Influence of pregnancy and oral contraception on the incidence of strokes in women of childbearing age. Lancet 1967 I, 1019–1023.
Jordan, W. M.: Pulmonary embolism. Lancet 1961 II, 1146–1147.
Lemmen, L. J., Davis, J. S., Radnor, L. L.: Complications in the surgery of internal carotid artery thrombosis. J. Neurosurg. 15, 438–446 (1958).
Levine, J., Swanson, P. D.: Nonatherosclerotic causes of stroke. Ann. intern. Med. 70, 807–816 (1969).
Lorentz, I. T.: Parietal lesion and “Enavid”. Brit. med. J. 1962 II, 1191.
Louis, S., McDowell, F.: Stroke in young adults. Ann. intern. Med. 66, 932–938 (1967).
Manalo-Estrella, P., Danforth, D. N., Buckingham, J. C.: Regression rate of vascular effects induced by pregnancy and by norethynodrel-mestranol. Fertil. and Steril. 16, 81–84 (1965).
Markush, R. E., Seigel, D. G.: Oral contraceptives and mortality trends from thromboembolism in the United States. Amer. J. publ. Hlth 59, 418–434 (1969).
Masi, A. T., Dugdale, M.: Cerebrovascular diseases associated with the use of oran contraceptives. A review of the english language literature. Ann. intern. Med. 72, 111–121 (1970).
Mauvais-Jarvis, P., de Lignières, B., Bercovici, J. P.: Les dangers de la contraception orale per les steroides oestroprogestatifs. Presse méd. 77, 1419–1422 (1969).
Mumenthaler, M., v. Roll, L.: Amnestische Episoden. Analyse von 16 eigenen Beobachtungen. Schweiz. med. Wschr. 99, 133–139 (1969).
Nevin, N. C., Elmes, P. C., Weaver, J. A.: Three cases of intravascular thrombosis occurring in patients receiving oral contraceptives. Brit. med. J. 1965 I, 1586–1589.
Oakley, C., Somerville, J.: Oral contraceptives and progressive pulmonary vascular disease. Lancet 1968 I, 890–893.
Phillips, L. L., Turksoy, R. N., Southam, A. L.: Influence of ovarian function on the fibrinolytic enzyme system. II influence of exogenous steroids. Amer. J. Obstet. Gynec. 82, 1216–1220 (1961).
Pindyck, J., Lichtman, H. C., Kohl, S. G.: Cryofibrinogenaemia in women using oral contraceptives. Lancet 1970 I, 51–53.
Probst, Ch.: Arterielle zerebrale Durchblutungsstörungen und andere neurologische Störungen bei Einnahme von Ovulationshemmern. Praxis 58, 45–46 (1969).
Reed, D. L., Coon, W. W.: Thromboembolism in patients receiving progestational drugs. New Engl. J. Med. 269, 622–624 (1963).
Reisner, H., Jaklitsch, H., Weissel, W.: Zerebrale Durchblutungsstörungen nach Gebrauch von Ovulationshemmern. Wien. med. Wschr. 119, 575–578 (1969).
Salmon, M. L., Winkelman, J. Z., Gay, A. J.: Neuro-ophthalmic sequelae in users of oral contraceptives. J. Amer. med. Ass. 203, 85–91 (1968).
Sartwell, P. E., Masi, A. T., Arthes, F. G., Greene, G. R., Smith, H. E.: Thromboembolism and oral contraceptives: an epidemiologic case-control study. Amer. J. Epidem. 90, 365–380 (1969).
Schatz, I. J., Smith, R. F., Breneman, G. M., Bower, G. C.: Thromboembolic disease associated with Norethynedrol. Report of six cases. J. Amer. med. Ass. 188, 493–495 (1964).
Schimmelpenning, G. W.: Probleme der modernen Antikonzeption in nervenärztlicher Sicht. Hippokrates (Stuttg.) 39, 765–769 (1968).
Schoenberg, B. S., Whisnant, J. P., Taylor, W. F., Kempers, R. D.: Stroke in women in childbearing age. A population study. Neurology (Minneap.) 20, 181–189 (1970).
Seigel, D., Corfman, P.: Epidemiological problems associated with studies of the safety of oral contraceptives. J. Amer. med. Ass. 203, 950–954 (1968).
Shafey, S., Scheinberg, P.: Neurological syndromes occurring in patients receiving synthetic steroids (oral contraceptives). Neurology (Minneap.) 16, 205–211 (1966).
Somers, J.: Recurrent stroke associated with the use of synthetic steroids. Case report. (Zit. b. Schoenberg.) Missouri Med. 64, 717 (1967).
Steinmann, B.: Zur Pathogenese der Apoplexic im Alter unter 50 Jahren. Schweiz. med. Wschr. 99, 1098–1106 (1969).
Stewart-Wallace, A. M.: Cerebrovascular accident and oral contraception. Brit. med. J. 1964 II, 1528.
Strang, C. D.: Polyneuritis and oral contraceptives. Brit. med. J. 1965 II, 879–880.
Thervet, F., Schneider, J.-J., Bland, D., Bernard, S., de Gennes, J. L., Rambert, P.: Accident ischémique aigu sous stéroide anovulatoire chez une femme de 29 ans atteinte d'hyperlipidémie familiale. Bull. Soc. Méd. Paris 118, 919–927 (1967).
Vessey, M. P., Doll, R.: Investigation of relation between use of oral contraceptives and thromboembolic disease. Brit. med. J. 1968 II, 199–205.
Walsh, F. B., Clark, D. B., Thompson, R. S., Nicholson, D. H.: Oral contraceptives and neuro-ophthalmologic interest. Arch. Ophthal. 74, 628–640 (1965).
Watson, H., Emslie-Smith, D., Herring, J., Hill, I. G. W.: Myocardial infarction during pregnancy and puerperium. Lancet 1960 II, 523–526.
Wells, C. E., Timberger, R. J.: Cerebral thrombosis in patients under fifty years of age. Arch. Neurol. (Chic.) 4, 268–271 (1961).
West, J., West, E. D.: The electroencephalogram and personality of women with headache on oral contraceptives. Lancet 1966 I, 1180–1182.
Whitty, C. W. M., Hockaday, J. M., Whitty, M. M.: The effect of oral contraceptives on migraine. Lancet 1966 I, 856–859.
Wilbert, L., Hillmer, T., Hunstein, W., Reisert, P., Kaboth, U., Creutzfeldt, W.: Einfluß oraler Ovulationshemmer auf klinisch-chemische Normalwerte. Dtsch. med. Wschr. 94, 844–849, 2522 (1969).
Wolf, S. M., Wagner, J. H., jr., Davidson, S.: Oral contraceptives and neurological illness. Bull. Los Angeles neurol. Soc. 32, 141–149 (1967).
Wright, I. S.: FDA report on Enovid: ad hoc advisory committee for evalutation of a possible etiologic relation with thrombolic conditions. J. Amer. med. Ass. 185, 776 (1963).
Wynn, V., Doar, J. W. H.: Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966 II, 715–719.
— Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1969 II, 761–765.
Zilkha, K. J.: Cerebrovascular accident and oral contraception. Brit. med. J. 1964 II, 1132–1133.
Oral contraceptives and thromboembolism. (Leading article.) Lancet 1967 I, 1039–1040.
Oral contraception and thrombo-embolic disease. A report by the records unit and research advisory service of the royal college of general practitioners. J. roy. Coll. gen. Practit. 13, 267–279 (1967).
Author information
Authors and Affiliations
Additional information
In gekürzter Form am 29. 4. 1970 vor der Berliner Gesellschaft für Psychiatrie und Neurologie vorgetragen.
Rights and permissions
About this article
Cite this article
Mumenthaler, M., Huber, P. & Grandjean, P. Cerebrovasculäre Insulte bei jungen Frauen Ätiologische Analyse. Z. Neurol. 198, 46–64 (1970). https://doi.org/10.1007/BF00316135
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00316135